Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk A/S (UK) (DE:NOV)
:NOV
RESEARCH TOOLSreports
Holding DE:NOV?
Track your performance easily
Novo Nordisk A/S (UK) (NOV) Ownership Overview
5.27% Insiders
13.68% Mutual Funds
<0.01% Other Institutional Investors
7.69% ETFs
73.36% Public Companies and
Individual Investors
The ownership structure of Novo Nordisk A/S (UK) (DE:NOV) stock is a mix of institutional, retail, and individual investors. Approximately 21.37% of the company’s stock is owned by Institutional Investors, 5.27% is owned by Insiders, and 73.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 19, 2024 | David Moore Executive Vice President Corporate Development | xxxxxxxxxxxxx | kr1773125 |
| Nov 13, 2024 | Christina Law Non Executive,director | xxxxxxxxxxxxx | kr966303 |
| Nov 12, 2024 | David Moore Executive Vice President Corporate Development | xxxxxxxxxxxxx | kr7538043 |
| Nov 08, 2024 | Kasim Kutay Non Executive,director | xxxxxxxxxxxxx | kr4736088225 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 177,562,868 | Insider | 5.24% | 14,810,873,946 | |
| 105,371,796 | Institution | 3.11% | 8,789,272,248 | |
| 51,338,067 | Institution | 1.51% | 4,282,210,845 | |
| 48,304,570 | Institution | 1.42% | 4,029,180,793 | |
| 43,105,182 | Institution | 1.27% | 3,595,489,441 | |
| 31,386,882 | Institution | 0.93% | 2,618,042,601 | |
| 28,446,716 | Institution | 0.84% | 2,372,797,475 | |
| 26,725,770 | Institution | 0.79% | 2,229,249,927 | |
| 26,413,256 | Institution | 0.78% | 2,203,182,509 | |
| 25,243,657 | Institution | 0.74% | 2,105,623,918 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 48,304,570 | Institution | 1.42% | 4,029,180,793 | |
| 43,105,182 | Institution | 1.27% | 3,595,489,441 | |
| 31,386,882 | Institution | 0.93% | 2,618,042,601 | |
| 28,446,716 | Institution | 0.84% | 2,372,797,475 | |
| 26,413,256 | Institution | 0.78% | 2,203,182,509 | |
| 23,824,468 | Institution | 0.70% | 1,987,246,525 | |
| 19,924,971 | Institution | 0.59% | 1,661,981,681 | |
| 19,862,013 | Institution | 0.59% | 1,656,730,228 | |
| 18,479,895 | Institution | 0.55% | 1,541,445,002 | |
| 14,889,269 | Institution | 0.44% | 1,241,943,706 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Novo Nordisk A/S (UK) (DE:NOV)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 5.27% is held by insiders, and 73.36% is held by retail investors.
What percentage of Novo Nordisk A/S (UK) (DE:NOV) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Novo Nordisk A/S (UK) (DE:NOV) stock is held by institutional investors.
What percentage of Novo Nordisk A/S (UK) (DE:NOV) stock is held by retail investors?
According to the latest TipRanks data, approximately 73.36% of Novo Nordisk A/S (UK) (DE:NOV) stock is held by retail investors.
Who owns the most shares of Novo Nordisk A/S (UK) (DE:NOV)?
Kasim Kutay owns the most shares of Novo Nordisk A/S (UK) (DE:NOV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.